Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli

被引:45
作者
Dautin, N [1 ]
Karimova, G [1 ]
Ullmann, A [1 ]
Ladant, D [1 ]
机构
[1] Inst Pasteur, Unite Biochim Cellulaire, CNRS, URA Biol Struct & Agents Infect 2185, F-75724 Paris 15, France
关键词
D O I
10.1128/JB.182.24.7060-7066.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We describe a genetic system that allows in vivo screening or selection of site-specific proteases and of their cognate-specific inhibitors in Escherichia coli. This genetic test is based on the specific proteolysis of a signaling enzyme, the adenylate cyclase (AC) of Bordetella pertussis. As a model system we used the human immunodeficiency virus (HIV) protease. When an HIV protease processing site, p5, was inserted in frame into the AC polypeptide, the resulting ACp5 protein retained enzymatic activity and, when expressed in an E. coli cya strain, restored the Cya(+) phenotype. The HIV protease coexpressed in the same cells resulted in cleavage and inactivation of ACp5; the cells became Cya(-). When the entire HIV protease, including its adjacent processing sites, was inserted into the AC polypeptide, the resulting AC-HIV-Pr fusion protein, expressed in E. coli cya, was autoproteolysed and inactivated: the cells displayed Cya- phenotype. In the presence of the protease inhibitor indinavir or saquinavir, AC-HIV-Pr autoproteolysis was inhibited and the AC activity of the fusion protein was preserved; the cells were Cya(+). Protease variants resistant to particular inhibitors could be easily distinguished from the wild type, as the cells displayed a Cya(-) phenotype in the presence of these inhibitors. This genetic test could represent a powerful approach to screen for new proteolytic activities and for novel protease inhibitors. It could also be used to detect in patients undergoing highly active antiretroviral therapy the emergence of HIV variants harboring antiprotease-resistant proteases.
引用
收藏
页码:7060 / 7066
页数:7
相关论文
共 42 条
[1]   CONSTRUCTION AND PROPERTIES OF A FAMILY OF PACYC184-DERIVED CLONING VECTORS COMPATIBLE WITH PBR322 AND ITS DERIVATIVES [J].
BARTOLOME, B ;
JUBETE, Y ;
MARTINEZ, E ;
DELACRUZ, F .
GENE, 1991, 102 (01) :75-78
[2]   BETA-GALACTOSIDASE CONTAINING A HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE CLEAVAGE SITE IS CLEAVED AND INACTIVATED BY HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE [J].
BAUM, EZ ;
BEBERNITZ, GA ;
GLUZMAN, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :10023-10027
[3]   Resistance of human immunodeficiency virus type 1 to protease inhibitors: Selection of resistance mutations in the presence and absence of the drug [J].
Borman, AM ;
Paulous, S ;
Clavel, F .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :419-426
[4]   GENETIC CHARACTERIZATION OF MUTATIONS WHICH AFFECT CATABOLITE-SENSITIVE OPERONS IN ESCHERICHIA-COLI, INCLUDING DELETIONS OF GENE FOR ADENYL-CYCLASE [J].
BRICKMAN, E ;
SOLL, L ;
BECKWITH, J .
JOURNAL OF BACTERIOLOGY, 1973, 116 (02) :582-587
[5]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[6]   A GENETIC SYSTEM FOR STUDYING THE ACTIVITY OF A PROTEOLYTIC-ENZYME [J].
DASMAHAPATRA, B ;
DIDOMENICO, B ;
DWYER, S ;
MA, J ;
SADOWSKI, I ;
SCHWARTZ, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4159-4162
[7]   Constrained evolution of human immunodeficiency virus type 1 protease during sequential therapy with two distinct protease inhibitors [J].
Dulioust, A ;
Paulous, S ;
Guillemot, L ;
Delavalle, AM ;
Boué, F ;
Clavel, F .
JOURNAL OF VIROLOGY, 1999, 73 (01) :850-854
[8]   THE CALMODULIN-SENSITIVE ADENYLATE-CYCLASE OF BORDETELLA-PERTUSSIS - CLONING AND EXPRESSION IN ESCHERICHIA-COLI [J].
GLASER, P ;
LADANT, D ;
SEZER, O ;
PICHOT, F ;
ULLMANN, A ;
DANCHIN, A .
MOLECULAR MICROBIOLOGY, 1988, 2 (01) :19-30
[9]   Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].
Hirsch, MS ;
Conway, B ;
D'Aquila, RT ;
Johnson, VA ;
Brun-Vézinet, F ;
Clotet, B ;
Demeter, LM ;
Hammer, SM ;
Jacobsen, DM ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Vella, S ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991
[10]   SELECTION AND CHARACTERIZATION OF BETA-LACTAM-RESISTANT ESCHERICHIA-COLI K-12-MUTANTS [J].
JAFFE, A ;
CHABBERT, YA ;
DERLOT, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :622-625